Search results
Results from the WOW.Com Content Network
DHL deployed its Asia Pacific Disaster Response Team to the disaster areas to provide on-the-ground logistics support to assist with the relief effort in the aftermath of the devastating Typhoon Haiyan. Three rotating teams made up of volunteer employees from the Asia Pacific region were based at the Mactan Cebu Airport on Cebu island ...
In China, human trials of a potential COVID-19 vaccine, developed jointly by German company BioNTech and Chinese company Fosun Pharmaceutical, began with over seventy participants. [ 146 ] Statistics Indonesia revealed that the Indonesian GDP contracted by 5.3 per cent in the second quarter of 2020, the largest decline since the 1997 Asian ...
On July 22, 2020, the U.S. government placed a conditional advance-purchase order of $2 billion with Pfizer to manufacture 100 million doses of a COVID-19 vaccine, with an option for 500 million more, for use in the United States if the vaccine was shown to be safe, effective, licensed, and authorized by the Food and Drug Administration (FDA).
Color coded map of Eastern Visayas showing the number of deaths caused by Typhoon Haiyan. More than 1,000 500-999 100-499 50-99 25-49 1-24 0. Condemnations of slow government action in the relief effort in response to the typhoon mounted days after the storm had passed.
Two Vietnamese vaccines have become the first vaccines to be developed in Southeast Asia to begin clinical trials. [70] As the majority of vaccine doses go to the United States and Europe, most drug companies are unwilling to share their technology and many countries can't afford to purchase the necessary doses.
Public health experts are warning of a ‘quad-demic’ this winter. Here’s where flu, COVID, RSV, and norovirus are spreading
(Reuters) -The Chinese-linked Salt Typhoon cyberespionage operation targeted AT&T and Verizon's systems, but the wireless carriers' U.S. networks are now secure as they work with law enforcement ...
The Blueprint listed a Global Target Product Profile (TPP) for COVID‑19, identifying favorable attributes of safe and effective vaccines under two broad categories: "vaccines for the long-term protection of people at higher risk of COVID‑19, such as healthcare workers", and other vaccines to provide rapid-response immunity for new outbreaks ...